256 related articles for article (PubMed ID: 24887075)
1. Complement activation in multiple sclerosis plaques: an immunohistochemical analysis.
Ingram G; Loveless S; Howell OW; Hakobyan S; Dancey B; Harris CL; Robertson NP; Neal JW; Morgan BP
Acta Neuropathol Commun; 2014 May; 2():53. PubMed ID: 24887075
[TBL] [Abstract][Full Text] [Related]
2. Complement is activated in progressive multiple sclerosis cortical grey matter lesions.
Watkins LM; Neal JW; Loveless S; Michailidou I; Ramaglia V; Rees MI; Reynolds R; Robertson NP; Morgan BP; Howell OW
J Neuroinflammation; 2016 Jun; 13(1):161. PubMed ID: 27333900
[TBL] [Abstract][Full Text] [Related]
3. Tissue microarray methodology identifies complement pathway activation and dysregulation in progressive multiple sclerosis.
Loveless S; Neal JW; Howell OW; Harding KE; Sarkies P; Evans R; Bevan RJ; Hakobyan S; Harris CL; Robertson NP; Morgan BP
Brain Pathol; 2018 Jul; 28(4):507-520. PubMed ID: 28707765
[TBL] [Abstract][Full Text] [Related]
4. The pathology of multiple sclerosis is location-dependent: no significant complement activation is detected in purely cortical lesions.
Brink BP; Veerhuis R; Breij EC; van der Valk P; Dijkstra CD; Bö L
J Neuropathol Exp Neurol; 2005 Feb; 64(2):147-55. PubMed ID: 15751229
[TBL] [Abstract][Full Text] [Related]
5. Complement activated C4d immunoreactive oligodendrocytes delineate small cortical plaques in multiple sclerosis.
Schwab C; McGeer PL
Exp Neurol; 2002 Mar; 174(1):81-8. PubMed ID: 11869036
[TBL] [Abstract][Full Text] [Related]
6. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
[TBL] [Abstract][Full Text] [Related]
7. Temporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease.
Stoltzner SE; Grenfell TJ; Mori C; Wisniewski KE; Wisniewski TM; Selkoe DJ; Lemere CA
Am J Pathol; 2000 Feb; 156(2):489-99. PubMed ID: 10666378
[TBL] [Abstract][Full Text] [Related]
8. Myelin and axon pathology in multiple sclerosis assessed by myelin water and multi-shell diffusion imaging.
Rahmanzadeh R; Lu PJ; Barakovic M; Weigel M; Maggi P; Nguyen TD; Schiavi S; Daducci A; La Rosa F; Schaedelin S; Absinta M; Reich DS; Sati P; Wang Y; Bach Cuadra M; Radue EW; Kuhle J; Kappos L; Granziera C
Brain; 2021 Jul; 144(6):1684-1696. PubMed ID: 33693571
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulins and complement in postmortem multiple sclerosis tissue.
Barnett MH; Parratt JD; Cho ES; Prineas JW
Ann Neurol; 2009 Jan; 65(1):32-46. PubMed ID: 19194879
[TBL] [Abstract][Full Text] [Related]
10. The association between neurodegeneration and local complement activation in the thalamus to progressive multiple sclerosis outcome.
Cooze BJ; Dickerson M; Loganathan R; Watkins LM; Grounds E; Pearson BR; Bevan RJ; Morgan BP; Magliozzi R; Reynolds R; Neal JW; Howell OW
Brain Pathol; 2022 Sep; 32(5):e13054. PubMed ID: 35132719
[TBL] [Abstract][Full Text] [Related]
11. Up-regulated production and activation of the complement system in Alzheimer's disease brain.
Yasojima K; Schwab C; McGeer EG; McGeer PL
Am J Pathol; 1999 Mar; 154(3):927-36. PubMed ID: 10079271
[TBL] [Abstract][Full Text] [Related]
12. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.
Kornek B; Storch MK; Weissert R; Wallstroem E; Stefferl A; Olsson T; Linington C; Schmidbauer M; Lassmann H
Am J Pathol; 2000 Jul; 157(1):267-76. PubMed ID: 10880396
[TBL] [Abstract][Full Text] [Related]
13. Complement activation at the motor end-plates in amyotrophic lateral sclerosis.
Bahia El Idrissi N; Bosch S; Ramaglia V; Aronica E; Baas F; Troost D
J Neuroinflammation; 2016 Apr; 13(1):72. PubMed ID: 27056040
[TBL] [Abstract][Full Text] [Related]
14. Axonal expression of sodium channels and neuropathology of the plaques in multiple sclerosis.
Bouafia A; Golmard JL; Thuries V; Sazdovitch V; Hauw JJ; Fontaine B; Seilhean D
Neuropathol Appl Neurobiol; 2014 Aug; 40(5):579-90. PubMed ID: 23659577
[TBL] [Abstract][Full Text] [Related]
15. Oxidative damage in multiple sclerosis lesions.
Haider L; Fischer MT; Frischer JM; Bauer J; Höftberger R; Botond G; Esterbauer H; Binder CJ; Witztum JL; Lassmann H
Brain; 2011 Jul; 134(Pt 7):1914-24. PubMed ID: 21653539
[TBL] [Abstract][Full Text] [Related]
16. Complement C1q-C3-associated synaptic changes in multiple sclerosis hippocampus.
Michailidou I; Willems JG; Kooi EJ; van Eden C; Gold SM; Geurts JJ; Baas F; Huitinga I; Ramaglia V
Ann Neurol; 2015 Jun; 77(6):1007-26. PubMed ID: 25727254
[TBL] [Abstract][Full Text] [Related]
17. Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease.
Singhrao SK; Neal JW; Morgan BP; Gasque P
Exp Neurol; 1999 Oct; 159(2):362-76. PubMed ID: 10506508
[TBL] [Abstract][Full Text] [Related]
18. Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination.
Storch MK; Piddlesden S; Haltia M; Iivanainen M; Morgan P; Lassmann H
Ann Neurol; 1998 Apr; 43(4):465-71. PubMed ID: 9546327
[TBL] [Abstract][Full Text] [Related]
19. Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination.
Liu Y; Given KS; Harlow DE; Matschulat AM; Macklin WB; Bennett JL; Owens GP
Acta Neuropathol Commun; 2017 Mar; 5(1):25. PubMed ID: 28340598
[TBL] [Abstract][Full Text] [Related]
20. Complement activation in the human brain after traumatic head injury.
Bellander BM; Singhrao SK; Ohlsson M; Mattsson P; Svensson M
J Neurotrauma; 2001 Dec; 18(12):1295-311. PubMed ID: 11780861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
